NGM313



NAME OF DRUG : NGM313

ALSO KNOWN AS : NGM313

LABORATORY : NGMBio

STATUS AND ADVANCEMENT

Type of drug : KLB-FGFR1c

Clinical trials advancement : Analysing Results Phase 1

Estimated time to market : 125 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON NGM313

SOME PUBLICATIONS RELATED WITH NGM313

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH NGM313


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE